.png){kind=icon}
.png){kind=icon}
Return
Effectiveness of lavender supplementation in treating the most common mental health conditions in primary care settings: a narrative review
.png){kind=icon}
PRE
AI
I
J
R
T
E
A
B
DOI：10.1016/j.hermed.2025.101050.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Introduction: Primary care providers (PCPs) are challenged to meet increasing psychiatric needs in the United States. The number of visits that PCPs managed for mental health concerns increased by fifty percent from 2006 to 2018. The most common mental health conditions in the United States that present to PCPs are anxiety, depression, and substance abuse disorders. Complementary and alternative medicines (CAMs) may provide a low-cost option with reduced psychotropic side effects. Objective: The objective of this review is to evaluate the effectiveness of lavender supplementation on reducing symptoms associated with generalized anxiety disorder, depression, and substance abuse disorder. Methods: CINAHL, Cochrane Central Register of Controlled Trials, and MEDLINE databases were searched. Systematic reviews with meta-analysis that reported outcomes associated with lavender supplementation for the aforementioned psychiatric diagnoses were included. Results: A total of 15 full-text articles were included in this narrative review. Lavender supplementation was reported to improve symptoms associated with anxiety and depression. One study reported decreased cigarette cravings in those who used lavender. Conclusion: Lavender offers a minimal side effect profile for treatment of mental health conditions and is beneficial when considering the significant side effects of mainstream therapies. Lavender is both effective in the treatment of anxiety and depression and allows for clinicians to offer more treatment options. Through providing more treatment options, lavender can fill in treatment gaps for those that are not candidates for standard therapies.
Keywords:
Aromatherapy
Depression
Generalized anxiety disorder
Silexan
Substance abuse disorder
Journal
J
IF:
1.9
Papers:
45
Citations:
0
Organization
No organization information available
Cited Papers